China’s Global Pharma Supply Chain Operations Resuming In Wake Of Outbreak, USP Says
USP reference standard sales showed slow resumption of API manufacturing in China and less-than-expected API use in India.
USP reference standard sales showed slow resumption of API manufacturing in China and less-than-expected API use in India.